Packing batteries with more punch
Indian researchers are working on cells that can store more energy, last longer
Cadila Healthcare Limited (Zydus Cadila) on Thursday informed that the company has launched a pressurized Metered Dose Inhaler (pMDI) — Forglyn pMDI for Chronic Obstructive Pulmonary Disease (COPD) patients in India.
The company informed that its Forglyn pMDI is India’s first pMDI with a combination of Long Acting Muscarinic Antagonist (LAMA) and Long Acting Beta Agonist (LABA) for the COPD patients.
Priced at ₹495 per pack, Forglyn pMDI has been developed in-house using Zydus’ innovations in formulation technology.
The administration of the two drugs Formoterol fumarate (LABA) + Glycopyrrolate (LAMA) in a single inhalation will improve outcomes due to the desired synergistic effect of the two drugs and a better adherence to the treatment, the company informed in a statement issued on Thursday.
Sharvil Patel, Managing Director, Cadila Healthcare Ltd, said, “With this new technology, we hope to bring much relief to patients suffering from COPD and help them improve their health and quality of life.”
The novel process for Forglyn pMDI developed Zydus’ Pharmaceutical Technology Centre, ensures that delivery of the two drugs administered simultaneously through the inhaler are consistent and uniform which is critical for inhalation products.
The process technology employed for the manufacturing of this product is simple, affordable and scalable. The company has also filed a patent application for the novel process of this product.
COPD is a common respiratory disorder characterised by progressive airflow obstruction due to alveolar and bronchial abnormalities and inflammation caused by exposure to noxious substances.
A highly debilitating disease, COPD impacts the normal daily activities and limits the quality of life.
The disease is progressive in nature and can sometimes worsen due to sudden exacerbations, leading to significant disability and death. COPD is the third leading cause of death worldwide and in India an estimated 55.3 million patients suffer from COPD as reported by The Lancet.
Zydus has more than 100 brands/SKUs in the therapeutic area of Asthma, COPD, Allergic Rhinitis, Idiopathic Pulmonary Fibrosis (IPF) & Cough and cold.
Indian researchers are working on cells that can store more energy, last longer
To fix a broken bone, doctors often harvest another bone from the patient’s body or from someone else. It ...
Superconductors from IIScScientists at IISc Bangalore have invented a device with a nanocrystal structure ...
Engineering and construction giant L&T has won a licence from the Council of Scientific & Industrial ...
Will a stock continue its current trend or will it reverse? We tell you how you can read chart patterns to ...
Sensex and Nifty 50 saw selling interest on Friday and slumped; selling pressure could continue
Investors with a long-term horizon can consider this offer
Most AMCs have been sending out cryptic e-mails. We tell you how to read between the lines
In these isolated times when people yearn for a slice of the familiar, amateur and professional chefs are ...
With strokes of quirky humour, Partha Pratim Deb uses pulp, terracotta, glass and discarded cloth to create ...
Given the events in Washington DC on January 6, this week’s quiz is all about buildings that house or housed ...
While good writing wars against the cliché, television gives it a natural home
Digital is becoming dominant media, but are companies and their ad agencies transforming fast enough to make a ...
Slow Network, promoted by journalist-lyricist Neelesh Misra, pushes rural products and experiences
How marketers can use the traditional exchange of festive wishes meaningfully
For Fortune, a brand celebrating its 20th anniversary, it was a rude shock to become the butt of social media ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...
Please Email the Editor